Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DNAI2 Antikörper (C-Term)

DNAI2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41653 unconjugated
Produktnummer ABIN1881264
  • Target Alle DNAI2 Antikörper anzeigen
    DNAI2 (Dynein, Axonemal, Intermediate Chain 2 (DNAI2))
    Bindungsspezifität
    • 13
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 484-513, C-Term
    Reaktivität
    • 28
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 24
    • 4
    Kaninchen
    Klonalität
    • 26
    • 2
    Polyklonal
    Konjugat
    • 18
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser DNAI2 Antikörper ist unkonjugiert
    Applikation
    • 28
    • 19
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This DNAI2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 484-513 amino acids from the C-terminal region of human DNAI2.
    Klon
    RB41653
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product DNAI2 Primärantikörper
  • Applikationshinweise
    WB: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Loges, Olbrich, Fenske, Mussaffi, Horvath, Fliegauf, Kuhl, Baktai, Peterffy, Chodhari, Chung, Rutman, OCallaghan, Blau, Tiszlavicz, Voelkel, Witt, Zietkiewicz, Neesen, Reinhardt, Mitchison, Omran: "DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm." in: American journal of human genetics, Vol. 83, Issue 5, pp. 547-58, (2008) (PubMed).

    Pennarun, Chapelin, Escudier, Bridoux, Dastot, Cacheux, Goossens, Amselem, Duriez: "The human dynein intermediate chain 2 gene (DNAI2): cloning, mapping, expression pattern, and evaluation as a candidate for primary ciliary dyskinesia." in: Human genetics, Vol. 107, Issue 6, pp. 642-9, (2001) (PubMed).

    Hanna, Kruskal, Ezekowitz, Bloom, Collier: "Role of macrophage oxidative burst in the action of anthrax lethal toxin." in: Molecular medicine (Cambridge, Mass.), Vol. 1, Issue 1, pp. 7-18, (1996) (PubMed).

  • Target
    DNAI2 (Dynein, Axonemal, Intermediate Chain 2 (DNAI2))
    Andere Bezeichnung
    DNAI2 (DNAI2 Produkte)
    Synonyme
    MGC115449 antikoerper, CILD9 antikoerper, DIC2 antikoerper, C030015H18Rik antikoerper, Dnai2 antikoerper, Gm728 antikoerper, Dnaic2 antikoerper, dynein axonemal intermediate chain 2 antikoerper, dynein axonemal intermediate chain 2 S homeolog antikoerper, dynein, axonemal, intermediate chain 2 antikoerper, DNAI2 antikoerper, dnai2.S antikoerper, dnai2 antikoerper, Dnaic2 antikoerper, Dnai2 antikoerper
    Hintergrund
    The protein encoded by this gene belongs to the dynein intermediate chain family, and is part of the dynein complex of respiratory cilia and sperm flagella. Mutations in this gene are associated with primary ciliary dyskinesia type 9. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
    Molekulargewicht
    68821
    NCBI Accession
    NP_001166281, NP_075462
    UniProt
    Q9GZS0
Sie sind hier:
Kundenservice